Stability-Indicating RP-HPLC Method for the Simultaneous Estimation of Doxofylline and Terbutalinesulphate in Pharmaceutical Formulations

Overview

Journal Sci Pharm

Publisher MDPI

Specialty Pharmacology

Date 2014 Feb 1

PMID 24482767

Authors

Gananadhamu Samanthula

Krishnaveni Yadiki

Shantikumar Saladi

Sreekanth Gutala

K V Surendranath

Affiliations

Soon will be listed here.

Abstract

An isocratic, stability-indicating, reversed-phase high-performance liquid chromatography (RP-HPLC) method was developed for the quantitative determination of doxofylline and terbutaline sulphate, used for the treatment of respiratory problems. The chromatographic separation was achieved on a Zorbax-SB Phenyl 250 × 4.6mm × 5 μm column with the mobile phase consisting of a mixture of 25 mM ammonium acetate (pH 5.0) : acetonitrile (85:15 %v/v) at a flow rate of 1.0 ml/min. The eluate was monitored at 274 nm using a PDA detector. Forced degradation studies were performed on the bulk sample of doxofylline and terbutaline sulphate using acid (0.1N HCl), base (0.1N NaOH), oxidation (10% hydrogen peroxide), photolytic, and thermal degradation conditions. Good resolution was observed between the degradants and analytes. Degradation products resulting from the stress studies did not interfere with the detection of doxofylline and terbutaline sulphate, thus the assay is stability-indicating. The method has the requisite accuracy, selectivity, sensitivity, and precision for the simultaneous estimation of doxofylline and terbutaline sulphate in bulk and pharmaceutical dosage forms. The limit of quantitation and limit of detection were found to be 1.16 μg/ml and 0.38 μg/ml for doxofylline, 2.08 μg/ml and 0.62 μg/ml for terbutaline sulphate, respectively.

References

Bone R, Hiller C . Modern treatment of bronchial asthma. JACEP. 1978; 7(7):269-75. DOI: 10.1016/s0361-1124(78)80337-2. View

Bellia V, Battaglia S, Matera M, Cazzola M . The use of bronchodilators in the treatment of airway obstruction in elderly patients. Pulm Pharmacol Ther. 2005; 19(5):311-9. DOI: 10.1016/j.pupt.2005.08.004. View

Revathi R, Ethiraj T, Thenmozhi P, Saravanan V, Ganesan V . High performance liquid chromatographic method development for simultaneous analysis of doxofylline and montelukast sodium in a combined form. Pharm Methods. 2013; 2(4):223-8. PMC: 3658081. DOI: 10.4103/2229-4708.93390. View

Tagliaro F, Dorizzi R, Frigerio A, Marigo M . Non-extraction HPLC method for simultaneous measurement of dyphylline and doxofylline in serum. Clin Chem. 1990; 36(1):113-5. View

Sankar J, Lodha R, Kabra S . Doxofylline: The next generation methylxanthine. Indian J Pediatr. 2008; 75(3):251-4. DOI: 10.1007/s12098-008-0054-1. View

Sreenivas N, Narasu M, Shankar B, Mullangi R . Development and validation of a sensitive LC-MS/MS method with electrospray ionization for quantitation of doxofylline in human serum: application to a clinical pharmacokinetic study. Biomed Chromatogr. 2008; 22(6):654-61. DOI: 10.1002/bmc.984. View

Lagana A, Bizzarri M, Marino A, Mancini M . Solid phase extraction and high performance liquid chromatographic determination of doxophylline in plasma. Biomed Chromatogr. 1990; 4(5):205-7. DOI: 10.1002/bmc.1130040507. View

Page C . Doxofylline: a "novofylline". Pulm Pharmacol Ther. 2010; 23(4):231-4. DOI: 10.1016/j.pupt.2010.04.002. View

Waldeck B . Beta-adrenoceptor agonists and asthma--100 years of development. Eur J Pharmacol. 2002; 445(1-2):1-12. DOI: 10.1016/s0014-2999(02)01728-4. View

10.

Hanna C, Eyre P . On the action of combination bronchodilators. Agents Actions. 1979; 9(4):301-9. DOI: 10.1007/BF01970652. View

11.

Joshi H, Patel A, Captain A . Spectrophotometric and reversed-phase high-performance liquid chromatographic method for the determination of doxophylline in pharmaceutical formulations. J Young Pharm. 2010; 2(3):289-96. PMC: 2964760. DOI: 10.4103/0975-1483.66791. View

12.

Sagar K, Kelly M, Smyth M . Simultaneous determination of salbutamol and terbutaline at overdose levels in human plasma by high performance liquid chromatography with electrochemical detection. Biomed Chromatogr. 1993; 7(1):29-33. DOI: 10.1002/bmc.1130070108. View

13.

Shenfield G . Combination bronchodilator therapy. Drugs. 1982; 24(5):414-39. DOI: 10.2165/00003495-198224050-00004. View

14.

Rasmussen J, Lunell E . Additive bronchodilator effects of terbutaline and enprofylline in asthma. Eur J Clin Pharmacol. 1987; 32(1):23-6. DOI: 10.1007/BF00609953. View

15.

Rao R, Gangu Naidu C, Guru Prasad K, Santhakumar B, Saida S . Development and validation of a stability indicating assay of doxofylline by RP-HPLC: ESI-MS/MS, ¹H and ¹³C NMR spectroscopic characterization of degradation products and process related impurities. J Pharm Biomed Anal. 2013; 78-79:92-9. DOI: 10.1016/j.jpba.2013.02.004. View

16.

Stalenheim G, Lindstrom B, Lonnerholm G . Oral terbutaline alone and in combination with theophylline: dose, plasma concentration, and effect in long-term treatment of bronchial asthma. Eur Respir J. 1989; 2(9):861-7. View

17.

Shukla D, Chakraborty S, Singh S, Mishra B . Doxofylline: a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease. Expert Opin Pharmacother. 2009; 10(14):2343-56. DOI: 10.1517/14656560903200667. View

18.

Rao R, Guru Prasad K, Gangu Naidu C, Saida S, Agwane S . Development of a validated LC-MS/MS method for determination of doxofylline on rat dried blood spots and urine: application to pharmacokinetics. J Pharm Biomed Anal. 2013; 78-79:211-6. DOI: 10.1016/j.jpba.2013.02.017. View

19.

McCarthy P, Atwal S, Sykes A, Ayres J . Measurement of terbutaline and salbutamol in plasma by high performance liquid chromatography with fluorescence detection. Biomed Chromatogr. 1993; 7(1):25-8. DOI: 10.1002/bmc.1130070107. View